pharma · Colorectal Cancer Screening · Screening for Colon Cancer · MRKR
ME Therapeutics
Marker Therapeutics
ME Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Vancouver, British Columbia, CA HQ
2018 Founded
4 Employees
Public company Type
MRKR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Vancouver, British Columbia, CA
- Founded
- 2018
- Employees
- 4
- Programs
- 13
- Drugs
- 10
- Patents
- 27
ME Therapeutics clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to ME Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
ME Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ME Therapeutics.
-
Low dose FRα vaccine — Phase 2
Clinical update -
FRα peptide plus Adjuvant (GM-CSF) — Phase 2
Clinical update -
Urinary EDC metabolite testing — Unknown
Clinical update -
Urinary EDC metabolite testing — Unknown
Clinical update -
blood sampling — Unknown
Clinical update -
blood sampling — Unknown
Clinical update -
MT-601 dose 200 million cells — Phase 1
Clinical update -
MT-401-OTS — Phase 1
Clinical update